Correlation Between Evolus and Lifecore Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Evolus and Lifecore Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evolus and Lifecore Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evolus Inc and Lifecore Biomedical, you can compare the effects of market volatilities on Evolus and Lifecore Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evolus with a short position of Lifecore Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evolus and Lifecore Biomedical.

Diversification Opportunities for Evolus and Lifecore Biomedical

-0.66
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Evolus and Lifecore is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Evolus Inc and Lifecore Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lifecore Biomedical and Evolus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evolus Inc are associated (or correlated) with Lifecore Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lifecore Biomedical has no effect on the direction of Evolus i.e., Evolus and Lifecore Biomedical go up and down completely randomly.

Pair Corralation between Evolus and Lifecore Biomedical

Given the investment horizon of 90 days Evolus Inc is expected to under-perform the Lifecore Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Evolus Inc is 1.01 times less risky than Lifecore Biomedical. The stock trades about -0.17 of its potential returns per unit of risk. The Lifecore Biomedical is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  531.00  in Lifecore Biomedical on August 24, 2024 and sell it today you would earn a total of  167.00  from holding Lifecore Biomedical or generate 31.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Evolus Inc  vs.  Lifecore Biomedical

 Performance 
       Timeline  
Evolus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evolus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Lifecore Biomedical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Lifecore Biomedical are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting fundamental indicators, Lifecore Biomedical reported solid returns over the last few months and may actually be approaching a breakup point.

Evolus and Lifecore Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Evolus and Lifecore Biomedical

The main advantage of trading using opposite Evolus and Lifecore Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evolus position performs unexpectedly, Lifecore Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifecore Biomedical will offset losses from the drop in Lifecore Biomedical's long position.
The idea behind Evolus Inc and Lifecore Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device